BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 25744631)

  • 1. Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells.
    Kern U; Wischnewski V; Biniossek ML; Schilling O; Reinheckel T
    Mol Cancer; 2015 Feb; 14():39. PubMed ID: 25744631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT).
    Serrano I; McDonald PC; Lock FE; Dedhar S
    Oncogene; 2013 Jan; 32(1):50-60. PubMed ID: 22310280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine cathepsins B and X promote epithelial-mesenchymal transition of tumor cells.
    Mitrović A; Pečar Fonović U; Kos J
    Eur J Cell Biol; 2017 Sep; 96(6):622-631. PubMed ID: 28495172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor‑β‑mediated epithelial‑mesenchymal transition.
    Zhang Q; Han M; Wang W; Song Y; Chen G; Wang Z; Liang Z
    Oncol Rep; 2015 Apr; 33(4):1851-9. PubMed ID: 25632968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
    Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
    Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
    Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
    J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin.
    Janda E; Nevolo M; Lehmann K; Downward J; Beug H; Grieco M
    Oncogene; 2006 Nov; 25(54):7117-30. PubMed ID: 16751808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
    Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
    Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHON, a novel secreted protein, regulates epithelial-mesenchymal transition through transforming growth factor-β signaling in human breast cancer cells.
    Li L; Liu DX; Zhang N; Liang Q; Feng J; Yao M; Liu J; Li X; Zhang Y; Lu J; Huang B
    Int J Cancer; 2015 Mar; 136(6):1285-95. PubMed ID: 25082541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
    Sokol JP; Neil JR; Schiemann BJ; Schiemann WP
    Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer.
    Andrade SS; Gouvea IE; Silva MC; Castro ED; de Paula CA; Okamoto D; Oliveira L; Peres GB; Ottaiano T; Facina G; Nazário AC; Campos AH; Paredes-Gamero EJ; Juliano M; da Silva ID; Oliva ML; Girão MJ
    BMC Cancer; 2016 Mar; 16():173. PubMed ID: 26931461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion.
    Wang Y; Lui WY
    Eur J Cancer; 2012 Dec; 48(18):3475-87. PubMed ID: 22647687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells.
    Gao J; Yan Q; Wang J; Liu S; Yang X
    J Cell Physiol; 2015 Apr; 230(4):775-82. PubMed ID: 25205054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RSK3 switches cell fate: from stress-induced senescence to malignant progression.
    Huna A; Flaman JM; Lodillinsky C; Zhu K; Makulyte G; Pakulska V; Coute Y; Ruisseaux C; Saintigny P; Hernandez-Vargas H; Defossez PA; Boissan M; Martin N; Bernard D
    J Exp Clin Cancer Res; 2023 Nov; 42(1):318. PubMed ID: 38008756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor β signaling regulates the invasiveness of normal mammary epithelial cells and the metastasis formation of tumor cells.
    Vafaizadeh V; Graab U; Darvishi T; Machado R; Groner B
    Horm Mol Biol Clin Investig; 2012 Jun; 10(1):227-39. PubMed ID: 25436679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of transforming growth factor-β release from tumor cells reduces their motility associated with epithelial-mesenchymal transition.
    Ohshio Y; Teramoto K; Hashimoto M; Kitamura S; Hanaoka J; Kontani K
    Oncol Rep; 2013 Aug; 30(2):1000-6. PubMed ID: 23715805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.